肾结石管理随机对照试验的统计脆弱性:AUA与EAU指南分析
该研究评估美国泌尿外科学会(AUA)和欧洲泌尿外科学会(EAU)肾结石管理指南引用的随机对照试验(RCT)结局的统计脆弱性,采用脆弱指数(FI)、反向脆弱指数(rFI)和脆弱商(FQ)。共分析138项RCT的1210个结局,中位FI在AUA为4、EAU为5,超过62%的结局仅需少于5例事件反转即可改变显著性。结论认为这些RCT存在统计脆弱性,P值作为唯一证据强度指标有局限性。
要点
- AUA和EAU肾结石指南引用的RCT结局中位FI分别为4和5,统计脆弱性明显。
- 超过62%的结局仅需少于5例事件反转即可使显著性改变。
- 部分结局失访数超过FI,提示结果稳健性不足。
核心结论
- AUA和EAU肾结石指南引用的RCT存在统计脆弱性,P值不应作为唯一证据强度指标。
研究设计与样本
- 研究筛选AUA和EAU肾结石指南引用的双臂RCT,要求至少有一个二分类结局,共纳入138项RCT的1210个结局。
- 使用2×2列联表计算FI(调整事件直至P≥0.05)、rFI(调整非显著结局直至P<0.05)和FQ(FI除以样本量)。
主要发现
- AUA引用研究的中位FI为4(IQR 3-6),FQ为0.05(0.03-0.09);EAU引用研究的中位FI为5(IQR 3-7),FQ为0.04(0.02-0.06)。
- 超过62%的结局需要少于5例事件反转即可改变显著性。
- AUA的11.8%结局和EAU的14.2%结局中,失访数超过FI。
临床怎么用
- 临床解读肾结石RCT时,应结合FI、rFI和FQ评估证据稳健性,而非仅依赖P值。
- 未来研究应纳入FI、rFI和FQ以增强临床决策支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the statistical fragility of randomized controlled trials (RCTs) outcomes cited by the American Urological Association (AUA) and European Association of Urology (EAU) nephrolithiasis management guidelines using the fragility index (FI), reverse fragility index (rFI), and fragility quotient (FQ). METHODS: Two-armed RCTs with at least one dichotomous outcome cited by the AUA and EAU were identified. FI was calculated using a 2 × 2 contingency table, adjusting events until statistical significance was lost (P ≥.05). rFI was determined by modifying nonsignificant outcomes until significance was achieved (P <.05). FQ was calculated by dividing FI by sample size. RESULTS: A total of 1210 outcomes from 138 RCTs were analyzed. The median FI for AUA-cited studies was 4 (IQR 3-6) with an FQ of 0.05 (0.03-0.09), while for EAU-cited studies, median FI was 5 (3-7) with an FQ of 0.04 (0.02-0.06). Over 62% of outcomes required fewer than five event reversals to alter significance. No significant difference in FI (P = .375) or FQ (P = .080) was found between AUA and EAU studies. With respect to median publication year, FI significantly increased in EAU studies published after 2015 (P = .001), and FQ in AUA studies was significantly higher after 2006 (P = .004). In 11.8% of AUA and 14.2% of EAU outcomes, loss to follow-up exceeded the FI. CONCLUSION: RCTs cited in AUA and EAU nephrolithiasis guidelines demonstrate statistical fragility. The findings underscore the limitations of P-values as a sole measure of evidence strength. Future research should incorporate FI, rFI, and FQ to enhance clinical decision-making.
引用
- Kim E, Wang D, Nguyen N, et al. The Statistical Fragility of Randomized Controlled Trials in Kidney Stone Management: An Analysis of American Urological Association and European Association of Urology Guidelines. Urology. 2025. PMID: 40436073. doi:10.1016/j.urology.2025.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。